{"name":"Eledon Pharmaceuticals","slug":"eledon-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNWWN5b2dNZEhsQndXbWNkZ292aXlSR21aR09iTXpURmZPSE5iZm5oRElFd0ZtUDREb0FNUHYxeFVURjg1SGxaWTQtbl9fZnZFMEUxYkdaWHFwRU5QMnFlaXVrQUlfa1psMVFoVHZJZDJkVVNmTng5WUROVTNtMDUzd2FRWUJwazdFXy12QVZn?oc=5","date":"2026-03-10","type":"regulatory","source":"Seeking Alpha","summary":"Eledon Pharma wins FDA orphan status for lead asset (ELDN) - Seeking Alpha","headline":"Eledon Pharma wins FDA orphan status for lead asset (ELDN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxONFJQeWhTRnBfaTEyay1SMkpQZXFBMVNnQ2g0ZTVQdjdrcHM1cVBQVXdENUhfdDQ5b2pJbXprZnVSTTlFa3pvRnVmRl9KQ0RpMHpxaGMya2djX1l0cWNxM3MwcGlkRjZmQmo0dGJYMUVVdEIycG1DX3p6SWhzWTAxeUtlRGRVbGREaGJ1MWJ1TkIwaW91dGZCaHhPdldXc3o5bXBSQVNkWGRjSWsyd0JvUUp1azg?oc=5","date":"2026-01-23","type":"trial","source":"Stock Titan","summary":"2-year transplant data: Eledon's tegoprubart shows no rejection in 8 patients - Stock Titan","headline":"2-year transplant data: Eledon's tegoprubart shows no rejection in 8 patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSF83Z2psY3oyQmJZeUFQSkl2TC1aODBjNWZERkNkVzI3Zlp3WHNETXJpZjEycW1TOTZzd18yREhfQjltRXZtLXdxTW1ya0FHOVB1VXZ2RXRnZVhLZHo5YUcyclpYdng0UjNWOUZDaUlCMktqREpiLVAyc3pCbUFDeFZ1MnF1cUo4TVNRQ2lBR0ZJbXFtMlhiZXJubENVamRvOE5WRDhOZll1NUQ3OVdfUS10YU1fWVBEWHdj?oc=5","date":"2026-01-08","type":"pipeline","source":"Stock Titan","summary":"Drug helped 6 people stop using insulin and enable pig-to-human kidneys - Stock Titan","headline":"Drug helped 6 people stop using insulin and enable pig-to-human kidneys","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZG5NendDOTNoMTlNZWpzeERxWFN2RjFacDdscDQ5UjVQel9kbE81OWpMM2pqcXVEWXRmc18teDJRODRjV3kyVVp6cUhUUkVDYmI0UVlGVnFKcW5OdnlCZVV5Q0FqSGZvckwxbDlqa1FsVkV3R1lyUjNvMXBITm14TG40MXRGTVRXZ2t4a0s2cHJjd2pkTXRsaTd6T2RTQ01QbnRwZDJsMEttTGx4SHduZHlpd180dzVKZ1E?oc=5","date":"2025-11-19","type":"trial","source":"Clinical Trials Arena","summary":"Eledon’s transplant rejection drug shows promise in Phase I/II diabetes trial - Clinical Trials Arena","headline":"Eledon’s transplant rejection drug shows promise in Phase I/II diabetes trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxObHMyajF3c3hwdkFoWHpUS29zSzB1d2dBekg3bmxEWEU0ZXMzamJ2bEc2VXNTNDU2d2plUjFQUXJ5TnZ5QlFOTkxxWUxNdTlRTmdZdVl5YnZUNWhCejBXVmVvVnNLX3RyaVlkLTllUWdoLXJqZTlwTGZXb2l6aXRZZHA1OWt6Ujk3TUV0MzV5VHd2eUZlMlVRV2MtbUlvajBuakZER2VyMjJTY05CcjZjTTJYTkUwRGZILUU3ZFEwc2FHOHNVY1N3WXEtXzE3WXNVMzFCOF9icy1WNTlEWjhwMWU3MDBwUVFYMXNQcGkwOWpIeURObmpULVFrTDIwd0JWekY0SV91M3dYZDI1akRQUWpqMmNuWWRjMlExWDgwY3Y?oc=5","date":"2025-11-12","type":"pipeline","source":"GlobeNewswire","summary":"Eledon Pharmaceuticals Announces Pricing of $50 Million - GlobeNewswire","headline":"Eledon Pharmaceuticals Announces Pricing of $50 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOaUpFV2xRdFBzcnNudUw5VS0yaURUTjZZZHQxaUpzR2dncW9ZUmN1eUk0RFFBeWdrbEoxSUhqMDZaeXZheGRvdXg5OW5DdEF6eDk2Z1pvZ1VqcWFGS3hEa0FOYldyWHlGTURYeFk1enoxejJ3WVNleF9ZYmNVbmMtNElLT0ZxYXNVcUtUMjdBeEdhdDkybG5nRi02MDdfbklpUmt2XzNIQjhHS0RBeWl0V2R2LThoTk5Mekh4bm9xUXpnMW5TSm5KOXh0Skp5SWUtRWRvbmpkNkRXMldwOWduWV9xODVnODQweVUtS0o3Y2FfYl9IRGVPUVBmSGtrS2ZYQVBRRFFCOU9DYWJvVFE?oc=5","date":"2025-11-10","type":"trial","source":"FinancialContent","summary":"Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern - FinancialContent","headline":"Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5EQ2tfSlpnZGRlLVI3TVFjR1EtRFRuVzl5ZnpiSWJYLXlLLTdMc2Q5RE5kNVYtV1ZyemlUX0p3ZEQ3WXFPRGpmXzFUMDJadWtqVXZn?oc=5","date":"2025-11-07","type":"trial","source":"FirstWord Pharma","summary":"Eledon pursues Phase III bid for kidney transplant drug despite mid-stage failure - FirstWord Pharma","headline":"Eledon pursues Phase III bid for kidney transplant drug despite mid-stage failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPVUxhYzdZU0NLMVdkN0lHVHJlMjktM2VFb0NjUGFfdXU4dlhkX2J3VHRLRllhaks0RUVpbklveFU1UzFCZnJxLXFtdS1tVmFvbWRFMERPRndCLTI1clBDLUpoQnVVWnBuNkZwU1IxZlZ2TDk0WmxMUV9OSXctS3Nyc1dodmpzTUV5bS15MQ?oc=5","date":"2025-11-07","type":"pipeline","source":"TipRanks","summary":"Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today? - TipRanks","headline":"Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPMnBvazdYa0FFaXN0YzdSUHdjUlFBbGhKM0lsNzNZelFCZmxUaUpnd2h4d2N6Y1hDdlRrOG9HS1JuM3htRjctdnRuWWJiRXROTVJsOFhlcGJRNHJnb1hxSEhrQ04wRFN5MjlqTzBBZ2FlTnBEOTNwNVdiTGU2dERvUDZHMmxidFU2MTh2dw?oc=5","date":"2025-10-09","type":"pipeline","source":"Yahoo Finance","summary":"Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance","headline":"Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) is largely controlled by institutional shareholders who own 51% of the compan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPUkFHZVhKSzZVSU9YRHFZb3VtclZMS3FqRVpHeFdLbFBCdTQxd2pQcENXNDB1aFJwdTFraTdDSXRmT0Fick1udENtQktTU0JON2E2QzQ4VTBSc0hRYWp5UjRrV2g3czc2S251eDNvbVNXUWNSS1FMZGVhdV83UFNOclh6N0NLRlk?oc=5","date":"2024-10-30","type":"pipeline","source":"pharmaphorum","summary":"Eledon drug helps transplants 'cure' type 1 diabetes - pharmaphorum","headline":"Eledon drug helps transplants 'cure' type 1 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPMDdONktHOXMyLVRPUmUzTVRfaFc1Wk1BZ21mQ1pZNTBlSmlrNEZhamV3YzJyX2pTVS1yUFdWczVnRWxzVUVURWRwZzB4V0tkb29UQ19HcGF4Z3ZRcjZVRlF0RVdvWmdxdVBzWGZsNGVCeE43VkNLWUxoZTltYncxdGp3bzB5dUtfS0djN1pxWXhVdmdZWjZyYUw5WDFLMTQ3SDNqOVpR?oc=5","date":"2024-10-29","type":"pipeline","source":"Breakthrough T1D","summary":"Novel way to protect transplanted cells shows promise - Breakthrough T1D","headline":"Novel way to protect transplanted cells shows promise - Breakthrough T1D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPaENJdmtrNUdNZzNudk1ESjlsb0JSZHUxQzFhd3M1ZldQcXh2ei1OMTlrakc4YUhGTHhWNXlLdFBRQk90X0lWNFYyLWZfdnF3S3NPYVlTaVh5a0pwYm93WjgwQjEtb2lsb3ZpbVZpQWc4V3JvQmVUWGJ3WnpRUnFrNG9zN3pXUjVYMko4aA?oc=5","date":"2024-04-01","type":"pipeline","source":"Pharma Voice","summary":"With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care - Pharma Voice","headline":"With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}